Fernandes, F.B. 2023. Major evidence of the GLP-1 analog (liraglutide) in the treatment of obesity: a systematic review. International Journal of Nutrology. 16, 2 (Apr. 2023). DOI:https://doi.org/10.54448/ijn23211.